Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Victoza Brings About No Effects To Help Control Heart Failure
Bidness, ETC
Tue, 11/10/15 - 03:54 pm
Tags:
diabetes, heart failure, Jardiance, Victoza, Novo Nordisk, Eli Lilly, Boehringer Ingelheim
These Drugs Could Deliver $5 Billion (or More) in Annual Sales
Motley Fool
Sun, 11/1/15 - 11:12 am
Tags:
Receptos, Celgene, ozanimod, Novo Nordisk, Intra-Cellular Therapies, ITI-007
Sanofi, Novo Slump as Diabetes Moves on From Insulin Tradition
Bloomberg
Thu, 10/29/15 - 09:36 am
Tags:
Sanofi, Novo Nordisk, diabetes, insulin, earnings
Who's Up Next? More Pharma Companies Expected To Settle Foreign Bribery Cases
Forbes
Wed, 10/14/15 - 02:15 pm
Tags:
FCPA, bribery, GSK, Bristol-Myers Squibb, Teva Pharmaceutical, Sanofi, AstraZeneca, UCB Pharma, Novartis, Novo Nordisk, Eli Lilly
Novo Nordisk chief Sørensen tops world's-best CEO ranking
Fierce Pharma
Tue, 10/13/15 - 06:12 pm
Tags:
Novo Nordisk, Lars Sorenson, Pharma CEOs
Why Novo Nordisk Is All in on New Diabetes Drug
TheStreet.com
Thu, 10/1/15 - 09:07 am
Tags:
Novo Nordisk, diabetes, insulin
Novo Nordisk: Has This Company Solved The Anti-Obesity Sector Woes?
Seeking Alpha
Tue, 09/29/15 - 08:58 am
Tags:
Novo Nordisk, Saxenda, obesity, Canada
Novo combats talk of insulin price war with 'moderate premium' on brand-new Tresiba
Fierce Pharma
Mon, 09/28/15 - 06:13 pm
Tags:
Novo Nordisk, insulin, Toujeo, Tresiba, diabetes, Sanofi
Novo scores a game-changing diabetes approval, reversing an embarrassing rejection
Fierce Biotech
Sat, 09/26/15 - 09:44 am
Tags:
Novo Nordisk, diabetes, Tresiba, FDA, Ryzodeg
Novo's weekly diabetes drug clears another Phase III hurdle
Fierce Biotech
Fri, 09/25/15 - 08:45 pm
Tags:
Novo Nordisk, diabetes, semaglutide, Bydureon, AstraZeneca
Novo Nordisk strikes deal with Iran government to produce insulin pens in the country
Fierce Pharma
Tue, 09/22/15 - 12:15 pm
Tags:
Novo Nordisk, diabetes, Iran, insulin pen, drug manufacturing
Lilly's Heart Study Sets Up Showdown With Novo's Victoza
Bloomberg
Fri, 09/18/15 - 09:36 pm
Tags:
Eii Lilly, Novo Nordisk, Victoza, Boehringer Ingelheim, diabetes, Jardiance
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Fierce Pharma
Wed, 09/16/15 - 06:01 pm
Tags:
Victoza, Lyxumia, Novo Nordisk, Sanofi, diabetes, GLP-1 agonist
Novo Nordisk tops total returns of big European pharma firms
Bloomberg
Wed, 09/16/15 - 08:47 am
Tags:
Novo Nordisk, Europe
Analysts bet Novo's insulin drug will get U.S. green light
Yahoo/Reuters
Tue, 09/15/15 - 11:34 am
Tags:
Novo Nordisk, FDA, insulin, diabetes, Tresiba
Novo Nordisk Launches Obesity Medication In Canada - How Did That Happen?
Seeking Alpha
Mon, 09/14/15 - 10:55 am
Tags:
Novo Nordisk, obesity, Saxenda, Canada, drug launches
Intarcia vs. Novo: Which has the most appealing diabetes PhIII program?
Fierce Pharma
Fri, 08/28/15 - 05:44 pm
Tags:
Novo Nordisk, Intarcia, diabetes, ITCA-650, Merck, Januvia, semaglutide
Novo Nordisk buys diabetes startups founded by Lilly R&D veteran
Fierce Biotech
Fri, 08/28/15 - 09:51 am
Tags:
Novo Nordisk, M&A, Eli Lilly, R&D, diabetes, Calibrium, MB2
Novo jumping into phase III trials for major oral diabetes candidate
BioPharma Dive
Thu, 08/27/15 - 11:36 am
Tags:
Novo Nordisk, diabetes, semaglutide, GLP-1 agonist
Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion
Bizjournals.com
Wed, 08/26/15 - 08:45 pm
Tags:
Novo Nordisk

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.